Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 2
1948 1
1950 1
1954 2
1956 1
1957 2
1958 1
1959 8
1960 1
1961 2
1962 2
1963 3
1964 3
1965 6
1966 11
1967 13
1968 9
1969 19
1970 11
1971 9
1972 21
1973 24
1974 23
1975 30
1976 23
1977 28
1978 40
1979 32
1980 45
1981 37
1982 39
1983 42
1984 57
1985 70
1986 52
1987 60
1988 60
1989 79
1990 72
1991 94
1992 98
1993 118
1994 108
1995 102
1996 124
1997 109
1998 130
1999 122
2000 156
2001 152
2002 143
2003 188
2004 191
2005 194
2006 201
2007 230
2008 246
2009 260
2010 274
2011 314
2012 346
2013 360
2014 414
2015 446
2016 473
2017 512
2018 501
2019 590
2020 686
2021 836
2022 698
2023 642
2024 309

Text availability

Article attribute

Article type

Publication date

Search Results

9,990 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Interstitial lung disease 2"
Page 1
Interstitial lung disease.
Antoniou KM, Margaritopoulos GA, Tomassetti S, Bonella F, Costabel U, Poletti V. Antoniou KM, et al. Eur Respir Rev. 2014 Mar 1;23(131):40-54. doi: 10.1183/09059180.00009113. Eur Respir Rev. 2014. PMID: 24591661 Free PMC article. Review.
Interstitial lung diseases are a group of diffuse parenchymal lung disorders associated with substantial morbidity and mortality. ...Early diagnosis and disease stratification is also important in the field of other interstitial lung …
Interstitial lung diseases are a group of diffuse parenchymal lung disorders associated with substantial morbidi …
Interstitial Lung Disease: A Review.
Maher TM. Maher TM. JAMA. 2024 May 21;331(19):1655-1665. doi: 10.1001/jama.2024.3669. JAMA. 2024. PMID: 38648021 Review.
IMPORTANCE: Interstitial lung disease (ILD) consists of a group of pulmonary disorders characterized by inflammation and/or fibrosis of the lung parenchyma associated with progressive dyspnea that frequently results in end-stage respiratory failure. .. …
IMPORTANCE: Interstitial lung disease (ILD) consists of a group of pulmonary disorders characterized by inflammation an …
Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment.
Conte P, Ascierto PA, Patelli G, Danesi R, Vanzulli A, Sandomenico F, Tarsia P, Cattelan A, Comes A, De Laurentiis M, Falcone A, Regge D, Richeldi L, Siena S. Conte P, et al. ESMO Open. 2022 Apr;7(2):100404. doi: 10.1016/j.esmoop.2022.100404. Epub 2022 Feb 24. ESMO Open. 2022. PMID: 35219244 Free PMC article. Review.
BACKGROUND: Drug-induced interstitial lung disease (DIILD) is a form of interstitial lung disease resulting from exposure to drugs causing inflammation and possibly interstitial fibrosis. ...Important components of the diagnostic p …
BACKGROUND: Drug-induced interstitial lung disease (DIILD) is a form of interstitial lung disease …
Drug-Induced Interstitial Lung Diseases.
Ng N, Padilla ML, Camus P. Ng N, et al. Immunol Allergy Clin North Am. 2023 May;43(2):341-357. doi: 10.1016/j.iac.2023.01.009. Epub 2023 Mar 1. Immunol Allergy Clin North Am. 2023. PMID: 37055092 Review.
Drug-induced interstitial lung disease (DI-ILD) is an increasingly common cause of morbidity and mortality as the list of culprit drugs continues to grow. ...
Drug-induced interstitial lung disease (DI-ILD) is an increasingly common cause of morbidity and mortality as the list …
Interstitial Pneumonia with Autoimmune Features.
Graney BA, Fischer A. Graney BA, et al. Ann Am Thorac Soc. 2019 May;16(5):525-533. doi: 10.1513/AnnalsATS.201808-565CME. Ann Am Thorac Soc. 2019. PMID: 30695649 Free PMC article. Review.
Interstitial pneumonia with autoimmune features (IPAF) is a research classification proposed by the European Respiratory Society/American Thoracic Society Task Force on Undifferentiated Forms of Connective Tissue Disease-associated Interstitial Lung …
Interstitial pneumonia with autoimmune features (IPAF) is a research classification proposed by the European Respiratory Society/Amer …
Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)-related interstitial lung disease/pneumonitis-Focus on proactive monitoring, diagnosis, and management.
Swain SM, Nishino M, Lancaster LH, Li BT, Nicholson AG, Bartholmai BJ, Naidoo J, Schumacher-Wulf E, Shitara K, Tsurutani J, Conte P, Kato T, Andre F, Powell CA. Swain SM, et al. Cancer Treat Rev. 2022 May;106:102378. doi: 10.1016/j.ctrv.2022.102378. Epub 2022 Mar 12. Cancer Treat Rev. 2022. PMID: 35430509 Free article. Review.
Trastuzumab deruxtecan (T-DXd; DS-8201) is an antibody-drug conjugate targeting human epidermal growth factor receptor 2. Interstitial lung disease (ILD)/pneumonitis is an adverse event associated with T-DXd; in most cases, it is low grade (grade 2 …
Trastuzumab deruxtecan (T-DXd; DS-8201) is an antibody-drug conjugate targeting human epidermal growth factor receptor 2. Intersti …
Contemporary Concise Review 2021: Interstitial lung disease.
McCarthy C, Keane MP. McCarthy C, et al. Respirology. 2022 Jul;27(7):539-548. doi: 10.1111/resp.14278. Epub 2022 May 5. Respirology. 2022. PMID: 35513341 Free PMC article. Review.
The last 2 years have presented previously unforeseen challenges in pulmonary medicine. Despite the significant impact of the SARS-CoV-2 pandemic on patients, clinicians and communities, advances in the care and understanding of interstitial lung di …
The last 2 years have presented previously unforeseen challenges in pulmonary medicine. Despite the significant impact of the SARS-Co …
Interstitial Lung Diseases in Developing Countries.
Rivera-Ortega P, Molina-Molina M. Rivera-Ortega P, et al. Ann Glob Health. 2019 Jan 22;85(1):4. doi: 10.5334/aogh.2414. Ann Glob Health. 2019. PMID: 30741505 Free PMC article. Review.
More than 100 different conditions are grouped under the term interstitial lung disease (ILD). A diagnosis of an ILD primarily relies on a combination of clinical, radiological, and pathological criteria, which should be evaluated by a multidisciplinary team …
More than 100 different conditions are grouped under the term interstitial lung disease (ILD). A diagnosis of an ILD pr …
Diagnostic Classification of Interstitial Lung Disease in Clinical Practice.
Adegunsoye A, Ryerson CJ. Adegunsoye A, et al. Clin Chest Med. 2021 Jun;42(2):251-261. doi: 10.1016/j.ccm.2021.03.002. Clin Chest Med. 2021. PMID: 34024401 Review.
Interstitial lung diseases (ILDs) are challenging to diagnose, requiring integration of multiple complex features that are often difficult to interpret. ...We highlight the increasing importance of taking a multipronged approach to ILD classification that ref …
Interstitial lung diseases (ILDs) are challenging to diagnose, requiring integration of multiple complex features that …
Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis.
Strykowski R, Adegunsoye A. Strykowski R, et al. Immunol Allergy Clin North Am. 2023 May;43(2):209-228. doi: 10.1016/j.iac.2023.01.010. Epub 2023 Mar 3. Immunol Allergy Clin North Am. 2023. PMID: 37055085 Review.
Idiopathic pulmonary fibrosis (IPF), a common interstitial lung disease (ILD), is a chronic, progressive fibrosing interstitial pneumonia, with an unknown cause. IPF has been linked to several genetic and environmental risk factors. Disease prog …
Idiopathic pulmonary fibrosis (IPF), a common interstitial lung disease (ILD), is a chronic, progressive fibrosing i …
9,990 results